Matches in Wikidata for { <http://www.wikidata.org/entity/Q37708759> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q37708759 description "article científic" @default.
- Q37708759 description "article scientifique" @default.
- Q37708759 description "articolo scientifico" @default.
- Q37708759 description "artigo científico" @default.
- Q37708759 description "artículu científicu espublizáu en 2010" @default.
- Q37708759 description "bilimsel makale" @default.
- Q37708759 description "scientific article published on 19 March 2010" @default.
- Q37708759 description "vedecký článok" @default.
- Q37708759 description "vetenskaplig artikel" @default.
- Q37708759 description "videnskabelig artikel" @default.
- Q37708759 description "vědecký článek" @default.
- Q37708759 description "wetenschappelijk artikel" @default.
- Q37708759 description "wissenschaftlicher Artikel" @default.
- Q37708759 description "наукова стаття, опублікована в березні 2010" @default.
- Q37708759 description "научни чланак" @default.
- Q37708759 description "مقالة علمية نشرت في 19 مارس 2010" @default.
- Q37708759 name "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 name "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 name "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 type Item @default.
- Q37708759 label "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 label "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 label "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 prefLabel "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 prefLabel "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 prefLabel "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 P1433 Q37708759-82AB7BD8-34F4-4DA1-86EC-DF77879F5821 @default.
- Q37708759 P1476 Q37708759-8DA11992-E446-4E45-9EF0-B725404E6E57 @default.
- Q37708759 P2093 Q37708759-A9994F57-294B-4C82-8AE8-8C7D97434F9C @default.
- Q37708759 P304 Q37708759-C4514B35-A534-43E9-AB2E-0A8D7F15297B @default.
- Q37708759 P31 Q37708759-80e499d2-03c3-4e78-b949-9e5d284006d8 @default.
- Q37708759 P31 Q37708759-91DEF71B-F862-4D19-AD25-EBDAE119052F @default.
- Q37708759 P356 Q37708759-61680E73-F1AD-4A1D-8CDF-4AC7A02BD341 @default.
- Q37708759 P433 Q37708759-3DE20A3A-77D6-4C5D-9A10-2A9B69B347CC @default.
- Q37708759 P478 Q37708759-4C9EE1AF-64D8-4DD9-BBA0-CE73F80B116C @default.
- Q37708759 P50 Q37708759-04A45717-478E-4D35-A1E7-B7288B0BC597 @default.
- Q37708759 P50 Q37708759-0CA2A9F2-74AF-40CC-9604-8BE19DED4BEC @default.
- Q37708759 P50 Q37708759-189433FF-4553-4C97-9942-F6516E0F06D3 @default.
- Q37708759 P50 Q37708759-272ECE3A-A85C-4273-8C4A-83C7C3CD3DFD @default.
- Q37708759 P50 Q37708759-31856DAC-D1EB-4D7C-8E14-41615EF0E16D @default.
- Q37708759 P50 Q37708759-AEDBA758-26FD-47D2-A50D-9D068D7A39A8 @default.
- Q37708759 P50 Q37708759-B1FBF20C-51C2-401E-A6F5-ACC50715ED9B @default.
- Q37708759 P50 Q37708759-EF02036C-15A4-4D47-991A-06EC7995A03F @default.
- Q37708759 P577 Q37708759-4FCCDC8A-72D9-4547-A8C8-05424FEE8E3D @default.
- Q37708759 P5875 Q37708759-56E46147-79C5-4568-A916-D059DD2B80CF @default.
- Q37708759 P698 Q37708759-670106F1-DEB7-49DC-BFEB-78EF0D91B7EF @default.
- Q37708759 P921 Q37708759-FB3033FE-D2D2-4ACC-8324-3087D79803CC @default.
- Q37708759 P356 J.PHRS.2010.02.014 @default.
- Q37708759 P698 20227503 @default.
- Q37708759 P1433 Q15724622 @default.
- Q37708759 P1476 "Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment" @default.
- Q37708759 P2093 "Antonella Farsetti" @default.
- Q37708759 P304 "3-10" @default.
- Q37708759 P31 Q13442814 @default.
- Q37708759 P31 Q7318358 @default.
- Q37708759 P356 "10.1016/J.PHRS.2010.02.014" @default.
- Q37708759 P433 "1" @default.
- Q37708759 P478 "62" @default.
- Q37708759 P50 Q114438884 @default.
- Q37708759 P50 Q114438915 @default.
- Q37708759 P50 Q40107985 @default.
- Q37708759 P50 Q55404825 @default.
- Q37708759 P50 Q56615926 @default.
- Q37708759 P50 Q56615953 @default.
- Q37708759 P50 Q57009781 @default.
- Q37708759 P50 Q63616772 @default.
- Q37708759 P577 "2010-03-19T00:00:00Z" @default.
- Q37708759 P5875 "41943022" @default.
- Q37708759 P698 "20227503" @default.
- Q37708759 P921 Q389735 @default.